Breast cancer medicines
Breast cancer treatment is not one drug. HER2-positive disease, HR-positive disease, and BRCA-associated disease use different medicines. This hub points you to packs we actually stock, then to the product page for price and checkout.
HER2-positive protocols often use trastuzumab (Herceptin), sometimes with pertuzumab (Perjeta) or ado-trastuzumab emtansine (Kadcyla).
HR-positive, HER2-negative advanced disease may use a CDK4/6 inhibitor such as palbociclib (Ibrance / Palbace / Palnat) with endocrine therapy.
Some patients with BRCA mutations may be prescribed olaparib (Lynparza). None of these are interchangeable without the oncologist.
Medicines we stock in this area
Each card opens the existing /shop product URL. Protocols are chosen only by the oncologist.
HER2
Herceptin Trastuzumab 660mg
Open productHER2
Perjeta Pertuzumab 420mg
Open productHER2-ADC
Kadcyla 160mg
Open productCDK4/6
Palbace Palbociclib 100mg
Open productPARP
Lynparza Olaparib 150mg
Open productInformation and pharmacy-access support only — not medical advice, diagnosis, or a treatment plan. Always follow your oncologist. Prescription required for oncology medicines.